Lurakem Study Quiz Link

Reviewed by Editorial Team
The ProProfs editorial team is comprised of experienced subject matter experts. They've collectively created over 10,000 quizzes and lessons, serving over 100 million users. Our team includes in-house content moderators and subject matter experts, as well as a global network of rigorously trained contributors. All adhere to our comprehensive editorial guidelines, ensuring the delivery of high-quality content.
Learn about Our Editorial Process
| By SUJIT
S
SUJIT
Community Contributor
Quizzes Created: 1 | Total Attempts: 98
| Attempts: 98
SettingsSettings
Please wait...
  • 1/10 Questions

    In the NMA study lurasidone was having less somnolence compared to Quetiapine & Ziprasidone.?

    • True
    • False
Please wait...
About This Quiz

This quiz assesses knowledge on Lurasidone, focusing on its USFDA approval for adolescent schizophrenia, long-term safety, and efficacy studies.

Lurakem Study Quiz Link - Quiz

Quiz Preview

  • 2. 

    In the NMA study lurasidone had better efficacy compared to Aripiprazole & Ziprasidone.?

    • True

    • False

    Correct Answer
    A. True
    Explanation
    The NMA study found that lurasidone had better efficacy compared to both Aripiprazole and Ziprasidone. This suggests that lurasidone was more effective in treating the condition or symptoms being studied than the other two medications.

    Rate this question:

  • 3. 

     In the long term use of lurasidone trail over 2 years, change in weight gain, BMI,glycemic indices & prolactin with lurasidone were not meaningful?

    • True

    • False

    Correct Answer
    A. True
    Explanation
    The statement suggests that in a long-term study of lurasidone, there were no significant changes observed in weight gain, BMI, glycemic indices, and prolactin levels. This implies that the use of lurasidone over a period of 2 years did not have a meaningful impact on these factors. Therefore, the answer "True" indicates that the statement is correct.

    Rate this question:

  • 4. 

    In the safety & efficacy study of lurasidone in long term, Lurasidone has high relapse rates.?

    • True

    • False

    Correct Answer
    A. False
    Explanation
    The statement "Lurasidone has high relapse rates" is false. This means that in the safety and efficacy study of lurasidone in the long term, lurasidone did not show high relapse rates.

    Rate this question:

  • 5. 

     Full form of CGI-BPS.?

    • Clinical global impression - blood pressure scale

    • Clinical global impression - bipolar scale

    • Clinical global impression - binary scale

    • Clinical global impression -British pharmacopoeia

    Correct Answer
    A. Clinical global impression - bipolar scale
    Explanation
    CGI-BPS stands for Clinical Global Impression - Bipolar Scale. This scale is used in clinical research and practice to assess the severity of illness and overall improvement in patients with bipolar disorder. It involves rating the patient's condition on a scale from 1 to 7, with 1 indicating normal, not ill, and 7 indicating extremely ill. The CGI-BPS helps clinicians and researchers in evaluating the effectiveness of treatments and tracking the progress of patients with bipolar disorder.

    Rate this question:

  • 6. 

    In the NMA study Olanzapine & Quetiapine had lesser weight gain compared to Lurasidone.?

    • True

    • False

    Correct Answer
    A. False
    Explanation
    The given statement is false. The NMA study shows that Olanzapine & Quetiapine had greater weight gain compared to Lurasidone.

    Rate this question:

  • 7. 

    In this safety & efficacy trail of 2 years with lurasidone discontinuation due to adverse events with lurasidone was relatively low as 6.6% ?

    • True

    • False

    Correct Answer
    A. True
    Explanation
    The explanation for the given correct answer is that in a safety and efficacy trial conducted over a period of 2 years with lurasidone, the discontinuation rate due to adverse events was relatively low at 6.6%. This suggests that the participants in the trial were able to tolerate the medication well and did not experience significant adverse effects that would require them to discontinue its use. Therefore, the statement that discontinuation due to adverse events with lurasidone was relatively low as 6.6% is true.

    Rate this question:

  • 8. 

    For which indication was the recent approval of Lurasidone from USFDA?

    • For schizophrenia aged between 13-17

    • For Bipolar disorder & schizophrenia aged between 13-17

    • For adolescent schizophrenia aged between 13-17

    • For Bipolar depression aged between 13-17

    Correct Answer
    A. For adolescent schizophrenia aged between 13-17
    Explanation
    The recent approval of Lurasidone from USFDA was for the indication of adolescent schizophrenia aged between 13-17.

    Rate this question:

  • 9. 

    In which journal(Name of the journal) the lurasidone safety & effectiveness got proved in 2 years of study?

    • International journal of bipolar disorder 2017

    • Bipolar journal psychiatry & mood disorders 2016

    • BPD psychiatry 2017

    • Indian Journal of Psychiatry disorders 2016

    Correct Answer
    A. International journal of bipolar disorder 2017
    Explanation
    The correct answer is the International Journal of Bipolar Disorder 2017.

    Rate this question:

  • 10. 

    Name of the journal where the NMA(Network Meta Analysis) of Lurasidone Vs other antipsychotics was published?

    • World Health Organisation 2017

    • World Journal of Biological psychiatry 2017

    • Bipolar disorder 2017

    • International journal of bipolar disorder 2017

    Correct Answer
    A. World Journal of Biological psychiatry 2017
    Explanation
    The correct answer is "World Journal of Biological psychiatry 2017". This journal is likely to be the one where the NMA of Lurasidone Vs other antipsychotics was published, as it specifically focuses on biological psychiatry and publishes research in this field.

    Rate this question:

Quiz Review Timeline (Updated): Jun 17, 2023 +

Our quizzes are rigorously reviewed, monitored and continuously updated by our expert board to maintain accuracy, relevance, and timeliness.

  • Current Version
  • Jun 17, 2023
    Quiz Edited by
    ProProfs Editorial Team
  • Jun 14, 2017
    Quiz Created by
    SUJIT
Back to Top Back to top
Advertisement
×

Wait!
Here's an interesting quiz for you.

We have other quizzes matching your interest.